Search Results

There are 43666 results for: content related to: Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma

  1. XXVII International Congress of the International Academy of Pathology October 12-17, 2008, Athens, Greece POSTER PRESENTATIONS


    Volume 53, Issue s1, October 2008, Pages: 1–432,

    Version of Record online : 24 SEP 2008, DOI: 10.1111/j.1365-2559.2008.03116.x

  2. Current management of ovarian carcinosarcoma

    International Journal of Gynecological Cancer

    Volume 17, Issue 2, March/April 2007, Pages: 316–324, M.S. MANO, D.D. ROSA, E. AZAMBUJA, G. ISMAEL, S. BRAGA, V. D’HONDT, M. PICCART and A. AWADA

    Version of Record online : 14 NOV 2006, DOI: 10.1111/j.1525-1438.2006.00760.x

  3. Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?

    International Journal of Gynecological Cancer

    Volume 16, Issue 1, January 2006, Pages: 416–422, M.R. RASPOLLINI, T. SUSINI, G. AMUNNI, M. PAGLIERANI, F. CASTIGLIONE, F. GARBINI, C. CARRIERO, G. SCARSELLI and G.L. TADDEI

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1525-1438.2006.00410.x

  4. You have free access to this content
    Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma


    Volume 98, Issue 1, 1 July 2003, Pages: 66–73, Estrid V. S. Høgdall, Lise Christensen, Susanne K. Kjaer, Jan Blaakaer, Johannes E. Bock, Eva Glud, Bent Nørgaard-Pedersen and Claus K. Høgdall

    Version of Record online : 22 MAY 2003, DOI: 10.1002/cncr.11476

  5. You have free access to this content
    Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (Malignant mixed müllerian tumors): Clinicopathologic study of 82 cases


    Volume 77, Issue 3, 1 February 1996, Pages: 533–542, Michael J. Costa and Judy Walls

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0142(19960201)77:3<533::AID-CNCR16>3.0.CO;2-5

  6. Correlation of p27 protein expression with HER-2/neu expression in breast cancer

    Molecular Carcinogenesis

    Volume 30, Issue 3, March 2001, Pages: 169–175, Lisa Newman, Weiya Xia, Heng-Yin Yang, Aysegal Sahin, Melissa Bondy, Farzana Lukmanji, Mien-Chie Hung and Mong-Hong Lee

    Version of Record online : 6 APR 2001, DOI: 10.1002/mc.1025

  7. You have free access to this content
    Preferred genetic evolutionary sequences in human breast cancer: A case study


    Volume 21, Issue 1, 1 September 1995, Pages: 6–13, Dr. Stanley E. Shackney, Charles A. Smith, Agnese A. Pollice, Laura E. Janocko, Sarita G. Singh, David W. Groft, Kathryn A. Brown and Robert J. Hartsock

    Version of Record online : 8 MAR 2005, DOI: 10.1002/cyto.990210104

  8. You have full text access to this OnlineOpen article
    TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma


    Volume 57, Issue 1, July 2010, Pages: 81–89, Elisa Rossi, Vincenzo Villanacci, Gabrio Bassotti, Francesco Donato, Andrea Festa, Gianpaolo Cengia, Salvatore Grisanti and Renzo Cestari

    Version of Record online : 16 JUN 2010, DOI: 10.1111/j.1365-2559.2010.03580.x

  9. Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?



    Version of Record online : 6 MAY 2003, DOI: 10.1034/j.1600-0463.2003.t01-1-1110210.x

  10. Proteomics of breast cancer: Enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors


    Volume 5, Issue 7, No. 7 May 2005, Pages: 1797–1805, Dao-Hai Zhang, Lee Kian Tai, Lee Lee Wong, Sunil K. Sethi and Evelyn S. C. Koay

    Version of Record online : 12 APR 2005, DOI: 10.1002/pmic.200401069

  11. Chondrosarcomatous differentiation in metastatic deposit of serous papillary cystadenocarcinoma

    Pathology International

    Volume 50, Issue 6, June 2000, Pages: 497–501, Hideharu Domoto, Yoshinori Mano, Tsunekazu Kita, Yoshihiro Kikuchi, Kimiya Sato, Shinsuke Aida and Seiichi Tamai

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1440-1827.2000.01062.x

  12. Significant prognostic factor of immunohistochemical HER-2 expression using initial prostate biopsy specimens with M1b prostate cancer

    The Prostate

    Volume 71, Issue 4, 1 March 2011, Pages: 385–393, Motoi Tobiume, Yoshiaki Yamada, Kogenta Nakamura, Shigeyuki Aoki, Kenji Zennami, Yoshiharu Kato, Genya Nishikawa, Toyoharu Yokoi and Nobuaki Honda

    Version of Record online : 1 SEP 2010, DOI: 10.1002/pros.21252

  13. You have free access to this content
    Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma


    Volume 97, Issue 7, 1 April 2003, Pages: 1758–1765, Fan Zhang, Ying Yang, Terry Smith, Shu-Wan Kau, Judy M. McConathy, Francisco J. Esteva, Henry M. Kuerer, W. Fraser Symmans, Aman U. Buzdar, Gabriel N. Hortobagyi and Lajos Pusztai

    Version of Record online : 18 MAR 2003, DOI: 10.1002/cncr.11245

  14. You have free access to this content
    Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer

    International Journal of Cancer

    Volume 98, Issue 6, 20 April 2002, Pages: 883–888, Gilbert Spizzo, Peter Obrist, Christian Ensinger, Igor Theurl, Martina Dünser, Angela Ramoni, Eberhard Gunsilius, Günther Eibl, Gregor Mikuz and Günther Gastl

    Version of Record online : 8 FEB 2002, DOI: 10.1002/ijc.10270

  15. Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast


    Volume 45, Issue 2, August 2004, Pages: 142–147, X Sastre-Garau, P Genin, A Rousseau, A Al Ghuzlan, A Nicolas, P Fréneaux, C Rosty, B Sigal-Zafrani, J Couturier, J-P Thiery, H Magdelénat and A Vincent-Salomon

    Version of Record online : 27 JUL 2004, DOI: 10.1111/j.1365-2559.2004.01899.x

  16. You have free access to this content
    Do we need HER-2/neu testing for all patients with primary breast carcinoma?


    Volume 98, Issue 12, 15 December 2003, Pages: 2547–2553, Susanne Taucher, Margaretha Rudas, Robert M. Mader, Michael Gnant, Peter Dubsky, Thomas Bachleitner, Sebastian Roka, Florian Fitzal, Daniela Kandioler, Emanuel Sporn, Josef Friedl, Martina Mittlböck and Raimund Jakesz

    Version of Record online : 22 OCT 2003, DOI: 10.1002/cncr.11828

  17. You have free access to this content
    HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma


    Volume 94, Issue 10, 15 May 2002, Pages: 2669–2674, Giovanni Selvaggi, Giorgio V. Scagliotti, Valter Torri, Silvia Novello, Eugenio Leonardo, Susanna Cappia, Claudio Mossetti, Francesco Ardissone, Paolo Lausi and Piero Borasio

    Version of Record online : 14 MAY 2002, DOI: 10.1002/cncr.10531

  18. Concordance of the Hormone Receptors and Correlation of HER-2/neu Overexpression of the Metachronous Cancers of Contralateral Breasts

    The Breast Journal

    Volume 11, Issue 3, May 2005, Pages: 183–187, Azadeh Stark, Mei Lu, Patricia Mackowiak and Michael Linden

    Version of Record online : 3 MAY 2005, DOI: 10.1111/j.1075-122X.2005.21579.x

  19. Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity

    Biotechnology and Bioengineering

    Volume 112, Issue 6, June 2015, Pages: 1102–1110, Jaina M. Patel, Vincent F. Vartabedian, Min-Chul Kim, Sara He, Sang-Moo Kang and Periasamy Selvaraj

    Version of Record online : 17 APR 2015, DOI: 10.1002/bit.25537

  20. You have free access to this content
    The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy


    Volume 16, Issue 6, November 1998, Pages: 413–428, Jeffrey S. Ross and Dr. Jonathan A. Fletcher

    Version of Record online : 1 NOV 1998, DOI: 10.1002/stem.160413